18004-Breast Cancer-NA-56

Breast Cancer

Single Arm, Open Label Phase 1b/2 Study of SGN-LIV1A inCombination with Pembrolizumab for First-Line Treatment ofPatients with Unresectable Locally-Advanced or MetastaticTriple-Negative Breast Cancer (SGNLVA-002)

  • Details

ClinicalTrials.gov ID: NCT03310957
Diagnosis Type: NA
USOR Number:

  • Address

4715 Arapahoe Avenue
Boulder, CO 80303
P: (303) 385-2068

Search by practice name, trial titles, indicators and specific disease types.